We are live on
!
Find out more
TCP
Tyndall Capital Partners Portfolio holdings
AUM
$452K
1-Year Est. Return
26.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.05%
1 Year Est. Return
+26.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$551K
AUM Growth
+$45.7K
(+9%)
Cap. Flow
+$48.3K
Cap. Flow
% of AUM
8.77%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cyclerion Therapeutics
CYCN
|
+$48.3K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
CCM
HIP
BPWM
NP
CP
AI
CAWM
ADIM
Tyndall Capital Partners's Q4 2023 Portfolio in Review
As of Q4 2023, Tyndall Capital Partners held 1 position worth $551K, up 9% from $505K the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tyndall Capital Partners deployed $48.3K of net new capital in Q4 2023, adding to 1 existing holding.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Tyndall Capital Partners added most to Cyclerion Therapeutics in Q4 2023, an estimated $48.3K increase.
- Tyndall Capital Partners's ten largest holdings make up 100% of its $551K portfolio in Q4 2023.
- Tyndall Capital Partners opened 0 new positions and closed 0 in Q4 2023.
- Tyndall Capital Partners's portfolio value rose 9% quarter-over-quarter to $551K.
Based on Tyndall Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.